Frontiers journals are at the top of citation and impact metrics
Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
The journal welcomes outstanding contributions in any domain of cancer research: from basic laboratory research to clinical investigation, from prevention to treatment, and from imaging studies to novel treatment strategies.
Frontiers in Oncology is a member of the Committee on Publication Ethics.
Short Name: Front. Oncol.
Electronic ISSN: 2234-943X
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Science Citation Index Expanded, CLOCKSS
PMCID: all published articles receive a PMCID
Frontiers in Oncology is composed of the following Specialty Sections:
The specialty sections of Frontiers in Oncology welcome submission of the following article types: Case Report, Clinical Trial, Correction, Editorial, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review, Technology Report, Book Review, Data Report, General Commentary, Protocols, Clinical Study Protocol and Classification.
When submitting a manuscript to Frontiers in Oncology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Oncology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com